Arkios focuses on assisting emerging biopharmaceutical and device companies with the early stages of regulatory strategic planning and implementation as well as in the filing of a successful Investigational New Drug/Investigational Device Exemption (IND/IDE) with the FDA.

We also design and manage the clinical development of emerging technologies in the biopharmaceutical and device areas through successful product out-licensing or registration.

ARKIOS Can Serve You With:
• Outsourcing a specific clinical trial management function.
• Comprehensive regulatory affairs assistance.
• Data management & biostatistics.
• Recruiting clinical research sites.
• Seeking early stage product development guidance in approaching the FDA.